Previously submitted to: JMIR Medical Informatics (no longer under consideration since Jan 16, 2021)
Date Submitted: Nov 23, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Jaya Ant Lion Optimization-Driven Deep Recurrent Neural Network for Cancer Classification Using Gene Expression Data
ABSTRACT
Background:
Cancer is one of the deadly diseases prevailing worldwide and the patients with cancer are rescued only when the cancer is detected at the very early stage. Early detection of cancer is essential as, in the final stage, the chance of survival is limited. The symptoms of cancers are rigorous and therefore, all the symptoms should be studied properly before the diagnosis.
Objective:
Propose an automatic prediction system for classifying cancer to malignant or benign.
Methods:
This paper introduces the novel strategy based on the JayaAnt lion optimization-based Deep recurrent neural network (JayaALO-based DeepRNN) for cancer classification. The steps followed in the developed model are data normalization, data transformation, feature dimension detection, and classification. The first step is the data normalization. The goal of data normalization is to eliminate data redundancy and to mitigate the storage of objects in a relational database that maintains the same information in several places. After that, the data transformation is carried out based on log transformation that generates the patterns using more interpretable and helps fulfill the supposition, and to reduce skew. Also, the non-negative matrix factorization is employed for reducing the feature dimension. Finally, the proposed JayaALO-based DeepRNN method effectively classifies cancer-based on the reduced dimension features to produce a satisfactory result.
Results:
The proposed JayaALO-based DeepRNN showed improved results with maximal accuracy of 95.97%, the maximal sensitivity of 95.95%, and the maximal specificity of 96.96%.
Conclusions:
The resulted output of the proposed JayaALO-based DeepRNN is used for cancer classification.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.